Literature DB >> 26207399

An Ounce of Prevention Saves Tons of Lives: Infection in Burns.

Nishant Merchant1,2,3, Karen Smith1,2,3, Marc G Jeschke1,2,3.   

Abstract

BACKGROUND: Modern day burn care continues to wage an uphill battle against an enemy that evolves faster than we can develop weapons. Bacteria (bioburden) are everywhere and can infiltrate anywhere within our susceptible population of burn patients. This is why prevention of infection is key to improving their survival and outcome.
PURPOSE: To reduce the incidence of infection in the burn patient population. MATERIALS: Review of pertinent recent literature regarding infection prevention and control in the intensive care unit setting.
RESULTS: We propose that bioburden is one of the central elements in the infectious cycle that is ever-present in burn units. The mechanism of bacterial entry into the unit and subsequent transmission and infection are delineated. Recommendations for mitigating this risk are provided to guide future clinicians in their care of burn patients.
CONCLUSIONS: The treatment of infection and sepsis against highly adaptable bacteria is often insurmountable by ill patients. In this process, bioburden needs to be corralled to have any success. Thus, preventing organisms from entering the unit and transferring onto other patients, and eliminating the bacteria dwelling in the unit are all necessary actions in this battle. Ultimately, maintaining a culture that is constantly wary of this risk only can achieve this goal.

Entities:  

Mesh:

Year:  2015        PMID: 26207399      PMCID: PMC4523002          DOI: 10.1089/sur.2013.135

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  71 in total

1.  Double-blind study of selective decontamination of the digestive tract in intensive care.

Authors:  J M Hammond; P D Potgieter; G L Saunders; A A Forder
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  In vitro bactericidal effects of 405-nm and 470-nm blue light.

Authors:  J Stephen Guffey; Jay Wilborn
Journal:  Photomed Laser Surg       Date:  2006-12       Impact factor: 2.796

3.  Device-associated infection rates, device use, length of stay, and mortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings.

Authors:  Bijie Hu; Lili Tao; Victor D Rosenthal; Kun Liu; Yang Yun; Yao Suo; Xiandong Gao; Ruisheng Li; Danxia Su; Hungmei Wang; Chunxia Hao; Wei Pan; Catherine L Saunders
Journal:  Am J Infect Control       Date:  2012-10-05       Impact factor: 2.918

4.  Cost savings from reduced catheter-related bloodstream infection after simulation-based education for residents in a medical intensive care unit.

Authors:  Elaine R Cohen; Joe Feinglass; Jeffrey H Barsuk; Cynthia Barnard; Anna O'Donnell; William C McGaghie; Diane B Wayne
Journal:  Simul Healthc       Date:  2010-04       Impact factor: 1.929

5.  Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population.

Authors:  Joan M Weber; Robert L Sheridan; Shawn Fagan; Colleen M Ryan; Mark S Pasternack; Ronald G Tompkins
Journal:  J Burn Care Res       Date:  2012 Jul-Aug       Impact factor: 1.845

6.  Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.

Authors:  Ersin Ulkür; Oral Oncul; Huseyin Karagoz; Esma Yeniz; Bahattin Celiköz
Journal:  Burns       Date:  2005-07-11       Impact factor: 2.744

7.  Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital.

Authors:  Megan Clancy; Amy Graepler; Michael Wilson; Ivor Douglas; Jeff Johnson; Connie Savor Price
Journal:  Infect Control Hosp Epidemiol       Date:  2006-09-20       Impact factor: 3.254

8.  Visible light-induced killing of bacteria as a function of wavelength: implication for wound healing.

Authors:  Anat Lipovsky; Yeshayahu Nitzan; Aharon Gedanken; Rachel Lubart
Journal:  Lasers Surg Med       Date:  2010-08       Impact factor: 4.025

9.  Validation of a screening tool for the early identification of sepsis.

Authors:  Laura J Moore; Stephen L Jones; Laura A Kreiner; Bruce McKinley; Joseph F Sucher; S Rob Todd; Krista L Turner; Alicia Valdivia; Frederick A Moore
Journal:  J Trauma       Date:  2009-06

10.  Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?

Authors:  Bala Hota
Journal:  Clin Infect Dis       Date:  2004-09-27       Impact factor: 9.079

View more
  4 in total

Review 1.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

2.  Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster.

Authors:  L E Pirii; A W Friedrich; J W A Rossen; W Vogels; G I J M Beerthuizen; M K Nieuwenhuis; A M D Kooistra-Smid; E Bathoorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-23       Impact factor: 3.267

3.  Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center.

Authors:  Yin-Yin Chen; Ping-Feng Wu; Chii-Shya Chen; Ian-Horng Chen; Wan-Tsuei Huang; Fu-Der Wang
Journal:  BMC Infect Dis       Date:  2020-03-04       Impact factor: 3.090

4.  Evaluation of burn wound healing activity of novel fusidic acid loaded microemulsion based gel in male Wistar albino rats.

Authors:  Mehmet Evren Okur; Şule Ayla; Vildan Yozgatlı; Neşe Buket Aksu; Ayşegül Yoltaş; Duygu Orak; Hande Sipahi; Neslihan Üstündağ Okur
Journal:  Saudi Pharm J       Date:  2020-02-03       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.